Thrombin-Generation-Assay Substance, fluorescent



Order
Quantity
Price
Status
25 mg 200 € available


Documents
Art. No. Z020
Synonym Z-Gly-Gly-Arg-AMC
Molecular Formula C30H34F3N7O9 (free base: C28H33N7O7)
Molecular Weight 693.63 (free base: 579.60)
Purity by HPLC >95 % (214 nm)
Appearance Pale yellow solid
Solubility 50 μM in 0.1% (v/v) DMSO / aqueous buffers
Application “Slow” acting thrombin substrate for the determination of thrombin generation in plasma
Also suitable for urokinase, trypsin, and tissue-type plasminogen
Storage Store at -20°C, desiccate
Reference(s) Kintigh J. et al. Res. Pract. Thromb. Haemost. 2017, 2, 42-48.
Devreese K. et al. Thromb. Haemost. 2007, 98, 600-613.
Hemker H.C. et al. Pathophysiol. Haemost. Thromb. 2002, 32, 249-253.
Zimmerman M. et al. PNAS 1978, 75, 750-753.
Note INTENDED FOR RESEARCH USE ONLY, NOT FOR USE IN HUMAN, THERAPEUTIC OR DIAGNOSTIC APPLICATIONS.

Products

  • Zedira offers a huge portfolio of reliable specialist transglutaminase related products meant to catalyze research and development, both in academia and industry.

News  

  • Zedira publication - Features of ZED1227: The First-In-Class Tissue Transglutaminase Inhibitor Undergoing Clinical Evaluation for the Treatment of Celiac Disease
  • Dr. Falk Pharma and Zedira announce start of the phase 2b real-life study of ZED1227 for the treatment of Celiac Disease
  • imageDr. Falk Pharma and Zedira announce successful completion of the phase 2a proof-of-concept study of ZED1227 for the treatment of Celiac Disease
  • imageDr. Falk Pharma und Zedira verkünden den erfolgreichen Abschluss der Phase 2a-Studie mit ZED1227 zur Behandlung von Zöliakie
  • imageReversibly acting transglutaminase 2 inhibitors: drug candidates for the treatment of fibrosis
  • imagePress release: Zedira announces ISO 9001:2015 certification

Blog  

  • DZG Aktuell: „Aufruf zur Teilnahme an einer weiteren Wirksamkeitsstudie mit dem Studienmedikament ZED1227“
  • imageDesign of Oral FXIIIa Blockers as Safer Anticoagulants – Mission Impossible?
  • imageMicrobial transglutaminase (MTG) enables efficient and site-specific conjugation to native antibodies without the need of antibody engineering

Events

  • 19th International Celiac Disease Symposium

    19.10.2022 - 22.10.2022
    Sorrento, Italy